Once a PMN is submitted, the regulatory body reviews the information to assess any potential risks. This review typically involves:
1. Risk Assessment: Evaluating the potential for human exposure and environmental release. 2. Hazard Assessment: Determining the toxicological properties and potential health effects. 3. Review Period: The review process generally takes 90 days, during which the regulatory body may request additional information.
If the substance is deemed safe, the manufacturer receives a notice allowing them to proceed with production. If risks are identified, the regulatory body may impose restrictions or require further testing.
